Skip to main content
Livermore
Livermore
ZHEN

AbCellera Biologics Inc.

ABCL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001703057

In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding AbCellera Biologics Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ABCL: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders1902203+15
Shares121.8M38.1K127.9M+6.15M (+5.1%)
Value$1.21B$376.6K$1.30B+$87.7M (+7.3%)

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (36)

Institutions that held AbCellera Biologics Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ABCL in Q4 2022
InstitutionSharesValue% of portfolio
Commonwealth of Pennsylvania Public School Empls Retrmt Sys250,248$2.54M0.02%
Ameriprise Financial Inc243,282$2.46M0.00%
Ensign Peak Advisors, Inc166,000$1.68M0.00%
Macquarie Group Ltd119,399$1.21M0.00%
Gsa Capital Partners LLP111,894$1.13M0.14%
Alyeska Investment Group, L.P.100,000$1.01M0.01%
Trexquant Investment LP97,842$991.1K0.03%
First Trust Advisors LP80,628$816.8K0.00%
Glenmede Trust Co NA68,685$695.8K0.00%
Aquatic Capital Management LLC60,900$614.0K0.04%
Truist Financial Corp51,543$522.1K0.00%
Algert Global LLC48,480$491.1K0.03%
AQR Capital Management LLC32,913$333.4K0.00%
SEI Investments Co31,640$320.5K0.00%
Gyon Technologies Capital Management, LP25,818$261.5K0.10%
Counterpoint Mutual Funds LLC15,625$158.3K0.17%
Point72 Middle East FZE15,031$152.3K0.01%
Bridgefront Capital, LLC13,770$139.5K0.10%
Cetera Advisors LLC13,648$138.3K0.00%
Victory Capital Management Inc13,444$136.2K0.00%
Kapitalo Investimentos Ltda11,900$120.5K0.10%
Ethic Inc.11,459$116.1K0.01%
Guggenheim Capital LLC10,624$107.6K0.00%
Renaissance Capital LLC8,976$90.9K0.07%
Belpointe Asset Management LLC3,404$34.5K0.00%
Belvedere Trading LLC1,861$18.9K0.01%
Global Retirement Partners, LLC624$6.32K0.00%
GWM Advisors LLC720$5.07K0.00%
Rockefeller Capital Management L.P.500$5.00K0.00%
Parallel Advisors, LLC179$1.81K0.00%
Money Concepts Capital Corp100$1.01K0.00%
Financial Synergies Wealth Advisors, Inc.89$9020.00%
Sofos Investments, Inc.10$440.00%
CWM, LLC27$00.00%
Coppell Advisory Solutions LLC348––
Coppell Advisory Solutions Corp.348––

Sold out (21)

Institutions that held AbCellera Biologics Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ABCL in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Arrowstreet Capital, Limited Partnership327,619$3.24M
Jump Financial, LLC230,400$2.28M
Bessemer Group Inc224,102$2.22M
Occudo Quantitative Strategies LP162,885$1.61M
SG Americas Securities, LLC160,643$1.59M
Aviva PLC154,325$1.53M
PDT Partners, LLC96,417$954.0K
ETF Managers Group, LLC84,143$832.0K
HSBC Holdings PLC79,799$797.0K
XTX Topco Ltd68,657$679.0K
Parallax Volatility Advisers, L.P.57,430$568.0K
Walleye Trading LLC36,525$361.0K
Point72 Hong Kong Ltd34,838$345.0K
JFS Wealth Advisors, LLC34,516$341.0K
Canada Pension Plan Investment Board31,293$310.0K
MML Investors Services, LLC16,509$163.0K
Quantamental Technologies LLC11,999$119.0K
Gryphon Financial Partners LLC10,490$104.0K
Credential Qtrade Securities Inc.109$1.08K
Bogart Wealth, LLC75$1.00K
IFP Advisors, Inc1,080–

Not filed for Q4 2022 yet (2)

Institutions that held AbCellera Biologics Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ABCL in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Jefferies Group LLC38,000$375.8K
American Portfolios Advisors75$742